This error combines two departures from an ideal sink prediction: resistance between the releasing surface and receiving liquid, and drug already present in that liquid. For the steady planar reservoir model in sink-boundary approximation error in drug release, let be the ideal flux, the mass-transfer Biot number for drug release and . Assume and , with concentrations expressed on compatible scales. ThenWriting the isolated resistance error as givesSimply adding and counts their overlap twice. For example, and give , rather than . This error uses the ideal flux as denominator; the overprediction relative to actual flux is .
A useful design calculation solves for how much bulk accumulation is permissible. For a requested tolerance ,The right side is nonnegative only if . Even zero initial bulk concentration cannot rescue too large an external resistance. At and , the permitted bulk fraction is about . For a maintained and a well-mixed receiving volume , this corresponds to about accumulated in the liquid, assuming no removal or other drug sources. This is an illustrative model calculation, not a general assay acceptance threshold.
Increasing receiving volume primarily limits ; changing flow or membrane transport can change . The FDA's adaptive-perfusion apparatus specifically replaces potentially rate-limiting passive membrane diffusion with pressure-driven tangential filtration.[ref]
Adaptive Perfusion: A Novel In Vitro Drug Release Testing Method for Complex Drug Products by the FDA. Technology Summary, conventional membrane transport versus pressure-driven separation
Comparing flow conditions and volumes can distinguish the two limitations. A finite reservoir, changing internal profile, partitioning or sampling requires its own mass balance before this steady expression can be interpreted as an error estimate. Articles by others on the same topic
There are currently no matching articles.